The Clinical Significance of Unknown Sequence Variants in BRCA Genes
Germline mutations in BRCA1/2 genes are responsible for a large proportion of hereditary breast and/or ovarian cancers. Many highly penetrant predisposition alleles have been identified and include frameshift or nonsense mutations that lead to the translation of a truncated protein. Other alleles co...
Main Authors: | Antonio Russo, Valentina Calò, Loredana Bruno, Laura La Paglia, Marco Perez, Naomi Margarese, Francesca Di Gaudio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/2/3/1644/ |
Similar Items
-
Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants
by: Cecilia Castillo, et al.
Published: (2022-06-01) -
Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants
by: M.-C. Villy, et al.
Published: (2021-08-01) -
Insights from 25 years of oncogenetics: one person’s perspective
by: Eitan Friedman
Published: (2023-05-01) -
Big Data Sharing: A Crucial Democratic Issue for Genomic Medicine
by: Benjamin Derbez
Published: (2018-11-01) -
Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain Significance
by: Steven Sorscher, et al.
Published: (2017-07-01)